| Literature DB >> 27620878 |
Antoine J Marchand1, Philippe Seguin2,3,4, Yannick Malledant2,3,4, Marion Taleb2, Hélène Raoult5, Jean Yves Gauvrit5,3.
Abstract
BACKGROUND: Computed tomography angiography (CTA) is largely performed in European countries as an ancillary test for diagnosing brain death. However, CTA suffers from a lack of sensitivity, especially in patients who have previously undergone decompressive craniectomy. The aim of this study was to assess the performance of a revised four-point venous CTA score, including non-opacification of the infratentorial venous circulation, for diagnosing brain death.Entities:
Keywords: Brain death diagnosis; Computed tomography angiography; Confirmatory test; Revised four-point venous score
Year: 2016 PMID: 27620878 PMCID: PMC5020015 DOI: 10.1186/s13613-016-0188-7
Source DB: PubMed Journal: Ann Intensive Care ISSN: 2110-5820 Impact factor: 6.925
Fig. 1CTA axial views (a, b) of a control patient. Arrows indicate SPV
Physiological parameters and catecholamine used at the time of CT angiography (n = 76)
| Body core temperature (°C) | 36.8 ± 1.1 [32.8–39.9]a |
| Mean arterial pressure (mmHg) | 80 ± 19 |
| Natraemia (mmol/l) | 147 ± 7 |
| PaCO2 (mmHg) | 37 ± 10 |
| Haemoglobin (g/dl) | 10.7 ± 2.3 |
| PaO2/FiO2 | 326 ± 105 |
| Diabetes insipidus | 59 (78 %) |
| Catecholamine useb | 72 (86 %) |
| Catecholamine dose (µg/kg min−1) | 0.04 ± 0.06 |
CTA, computed tomography angiography; PaCO2, carbon dioxide arterial pressure; PaO2, oxygen arterial pressure; FiO2, inspiratory oxygen fraction
aMean ± SD [lower bound − upper bound]
bNorepinephrine, n = 67; epinephrine, n = 1; norepinephrine–dobutamine, n = 3; norepinephrine–epinephrine, n = 1
Fig. 2Study’s flowchart
Fig. 3CTA axial views of a clinically brain-dead patient with a lack of SPV opacification (a) despite an enhanced bilateral C-MCA (b) (arrows)
CTAs with persistent opacified vessels among patients with a clinical brain death diagnosis (n = 83)
| Vessel type | CTA examination(s) in which vessel type is still opacified |
|---|---|
| 2 C-MCA (left and right) | 8 |
| 1 C-MCA (left or right) | 10 |
| ICV | 3 |
| BA | 15 |
| SPV | 4 |
Data are expressed as n. Considering ICV and SPV, there was no case where only one vessel side (left or right) was enhanced or not contrary to C-MCA
C-MCA cortical segment of middle cerebral artery, ICV internal cerebral vein, BA basilar artery, SPV superior petrosal vein
Fig. 4CTA axial views of a clinically brain-dead patient with a craniectomy and no opacification of the SPV (a) despite persistent enhancement of the bilateral C-MCA (b)